Stroes, Charlotte I.
62  Ergebnisse:
Personensuche X
?
2

A phase Ib/II study of regorafenib and paclitaxel in patien..:

Stroes, Charlotte I ; Schokker, Sandor ; Khurshed, Mohammed...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592211091 , 2022
 
?
9

Prolonged hematopoietic and myeloid cellular response in pa..:

Verweij, Simone L. ; Stiekema, Lotte C. A. ; Delewi, Ronak...
European Journal of Nuclear Medicine and Molecular Imaging.  45 (2018)  11 - p. 1956-1963 , 2018
 
?
11

A systematic review of HER2 blockade for the curative treat..:

Stroes, Charlotte I ; van den Ende, Tom ; Derks, Sarah.
Stroes , C I , van den Ende , T , Derks , S & van Laarhoven , H W M 2021 , ' A systematic review of HER2 blockade for the curative treatment of gastroesophageal adenocarcinoma : Successes achieved and opportunities ahead ' , Cancer Treatment Reviews , vol. 99 , 102249 . https://doi.org/10.1016/j.ctrv.2021.102249.  , 2021
 
?
12

A phase ii study demonstrates no feasibility of adjuvant tr..:

Stroes, Charlotte I ; Schokker, Sandor ; Molenaar, Remco J...
Stroes , C I , Schokker , S , Molenaar , R J , Mathôt , R A A , Bijlsma , M F , van der Woude , S O , Pereira , J P B , Hooijer , G K J , Verhoeven , R H A , Cats , A , Grootscholten , C , van Sandick , J W , Creemers , G-J , Nieuwenhuijzen , G A P , Mohammad , N H , Ruurda , J P , Meijer , S L , Hulshof , M C C M , Henegouwen , M I V B & van Laarhoven , H W M 2021 , ' A phase ii study demonstrates no feasibility of adjuvant treatment with six cycles of s-1 and oxaliplatin in resectable esophageal adenocarcinoma, with ercc1 as biomarker for response to sox ' , Cancers , vol. 13 , no. 4 , 839 , pp. 1-15 . https://doi.org/10.3390/cancers13040839.  , 2021
 
1-15